Aryan Malhotra

Aryan Malhotra

Auto-generated profile, based on publicly available information

Aryan Malhotra

New York Medical College School of Medicine

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2026 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Open access
ITIsaac B. Thorman
Isaac B. Thorman
AMAryan Malhotra
Aryan Malhotra
ASAriel Sacknovitz
Ariel Sacknovitz
NSNoah Schechter
Noah Schechter
AKAdam Christopher Kiss
Adam Christopher Kiss
FAFawaz Al-Mufti
Fawaz Al-Mufti
Clinicians require a simple way to estimate prognosis after acute ischemic stroke (AIS). Existing models are complex and difficult to apply at bedside. We hypothesized that, after accounting for premorbid health, stroke severity predicts survival, and that the National Institutes of Health Stroke Scale (NIHSS) could serve as the basis for clinically intuitive mortality estimation. We conducted a retrospective ecological cohort study using the TriNetX Research Network, a federated database of electronic health records from more than 100 healthcare organizations. Adults (≥18 years) with AIS and a documented admission NIHSS were included. Propensity score matching aligned each NIHSS level with NIHSS= 0 on demographics and comorbidities. The primary outcome was 90-day mortality. Linear regression models, trained on odd NIHSS values and tested on even values, evaluated performance. Functional outcomes were analyzed with competing-risk methods. Among 147,391 eligible patients (median NIHSS=4), mortality increased linearly with severity: 90-day mortality (%) ≈ 1.7 × NIHSS. Model performance was strong (training R2=0.993; testing R2=0.986). Overall predicted and observed mortality were similar (13.3% vs 12.6%, P = .22), and discrimination was high (AUC=0.96). Functional outcomes displayed an inverted "u" pattern, driven by the competing risk of mortality at higher NIHSS levels. In this large ecological analysis, stroke severity predicted mortality after accounting for pre-stroke health. A single equation based solely on NIHSS accurately approximated 90-day mortality after AIS. While subject to the limitations of population-level inference, this "1.7% equation" offers a transparent, scalable framework that may support bedside communication and guide future prospective validation.

5 June 2026 in Annals of Neurology
Verified
Journal Article
Closed access
ITIsaac B. Thorman
Isaac B. Thorman
ASAriel Sacknovitz
Ariel Sacknovitz
ALAustin G. Li
Austin G. Li
AMAryan Malhotra
Aryan Malhotra
PMPatrica Engel McGoldrick
Patrica Engel McGoldrick
FAFawaz Al-Mufti
Fawaz Al-Mufti

1 May 2026 in Stroke
Verified
Journal Article
Closed access
SAStaton G. Albert
Staton G. Albert
AJAarti Kishore Jain
Aarti Kishore Jain
AMAryan Malhotra
Aryan Malhotra
NANabeel Ahmed
Nabeel Ahmed
NGNimrod Gozum
Nimrod Gozum
FAFawaz Al-Mufti
Fawaz Al-Mufti
BACKGROUND: Acute ischemic stroke affecting the middle cerebral artery (MCA) remains a major global cause of death and disability. However, it remains unclear whether the laterality of MCA strokes independently influences inpatient outcomes. Despite the fact that the National Institutes of Health Stroke Scale score is heavily weighted toward left-sided acute ischemic stroke, we hypothesize that right MCA strokes (R-MCASs) are associated with worse inpatient outcomes because they would require more severe deficits to amount to a comparable National Institutes of Health Stroke Scale score for a left MCA stroke. METHODS: A retrospective cross-sectional analysis was conducted using data from the National Inpatient Sample between 2015 and 2022. This nationally representative sample included adult patients (aged ≥18 years) in the United States hospitalized primarily for MCA strokes and with reported National Institutes of Health Stroke Scale scores. Patients were stratified into R-MCAS and left MCA stroke. Outcomes included odds of inpatient mortality, routine discharge, complications, and receipt of reperfusion therapy. Propensity score–based inverse probability of treatment weighting is adjusted for confounding factors. Multivariable logistic regression evaluated adjusted odds ratios (aORs) and 95% CIs for all outcomes. RESULTS: Among 489 360 acute ischemic stroke hospitalizations, 263 495 (53.8%) were left MCA stroke, and 225 865 (46.2%) were R-MCAS. Following inverse probability of treatment weighting, R-MCASs were significantly more likely to receive endovascular thrombectomy (aOR, 1.26 [95% CI, 1.22–1.30]; P <0.001) and less likely to receive intravascular thrombolysis (aOR, 0.965 [95% CI, 0.937–0.994]; P =0.018). R-MCAS was associated with significantly increased odds of cerebral edema/herniation (aOR, 1.53 [95% CI, 1.47–1.59]; P <0.001), hemorrhagic transformation (aOR, 1.25 [95% CI, 1.20–1.30]; P <0.001), and sepsis (aOR, 1.35 [95% CI, 1.25–1.46]; P <0.001). Left MCA stroke was associated with a higher likelihood of coma (aOR, 0.920 [95% CI, 0.889–0.952]; P <0.001). R-MCAS had significantly higher odds of inpatient mortality (aOR, 1.19 [95% CI, 1.12–1.26]; P <0.001) and lower odds of routine discharge (aOR, 0.786 [95% CI, 0.760–0.812]; P <0.001). CONCLUSIONS: Patients with R-MCAS were more likely to receive endovascular thrombectomy and less likely to receive intravascular thrombolysis. R-MCASs were also associated with worse discharge disposition and increased likelihood of inpatient mortality. The National Institutes of Health Stroke Scale bias toward assessment and valuation of patients’ language abilities may place patients with R-MCAS at increased risk of adverse poststroke outcomes and complications. Recognition of the subtle signs of nondominant hemisphere strokes may lead to more rapid detection, effective treatment, and improved outcomes.

9 May 2026 in Heart & Lung
Verified
Journal Article
Open access
AMAryan Malhotra
Aryan Malhotra
JBJames M Beck
James M Beck
MBMatthew Blacker
Matthew Blacker
JRJuhi Ramchandani
Juhi Ramchandani
DSDamien Smith
Damien Smith
GLGregg M Lanier
Gregg M Lanier
Acute myocardial infarction complicated by cardiogenic shock (AMI-CS) carries the highest in-hospital mortality among acute coronary syndromes, with medical management and various adjunctive therapies employed to care for these critically-ill patients. Intra-aortic balloon pumps (IABP) are a widely-used therapy, thus we aim to evaluate differences in mortality, clinical outcomes, and hospital courses of patients with AMI-CS treated with IABP versus non-IABP medical management. We conducted a retrospective cohort study of the National Inpatient Sample database between October 2015 and December 2022, including patients ≥18 years-old hospitalized with AMI and subsequent CS. Propensity score-based inverse probability of treatment weighting and multivariable logistic regression estimated adjusted odds ratios (aORs) with 95% confidence intervals (CIs). Among 247,825 AMI-CS hospitalizations, 84,635 (34.2%) involved IABP. IABP was associated with lower odds of both routine discharge (aOR: 0.837, 95% CI [0.794-0.882], p < 0.001) and inpatient mortality (0.653[0.623-0.684], p < 0.001), increased thrombocytopenia (2.10[1.98-2.22], p < 0.001) and lower acute kidney injury (0.816[0.783-0.849], p < 0.001). These patients also had higher odds of papillary muscle rupture (3.58[2.50-5.12], p < 0.001) and left ventricular wall rupture (1.67[1.17-2.39], p = 0.005). Despite greater baseline sickness, IABP was linked with a significant inpatient mortality reduction in AMI-CS. Increased thrombocytopenia and non-routine discharge potentially reflect treatment-related morbidity as a result of survivorship bias compared to patients receiving medical management alone. Prospective studies are needed to refine patient selection and mitigate device-related complications.

17 October 2026 in Neurology Clinical Practice
Verified
Journal Article
Closed access
ITIsaac B. Thorman
Isaac B. Thorman
EFEric Feldstein
Eric Feldstein
ASAriel Sacknovitz
Ariel Sacknovitz
AMAryan Malhotra
Aryan Malhotra
MSMichael C. Schubert
Michael C. Schubert
SWSteven Wolf
Steven Wolf

2 October 2024 in medRxiv
Verified
Preprint
Open access
PDF file
AMAryan Malhotra
Aryan Malhotra
AJAnkita Jain
Ankita Jain
ESEris Spirollari
Eris Spirollari
RKRachid Kaddoura
Rachid Kaddoura
MAMelinda Christine Arthur
Melinda Christine Arthur
FAFawaz Al-Mufti
Fawaz Al-Mufti
Introduction/Purpose Cerebral venous thrombosis (CVT) is a rare condition that presents significant treatment challenges and has traditionally been managed with anticoagulation. However, for patients who fail anticoagulation or present with severe symptoms, endovascular thrombectomy (EVT) has emerged as a favorable treatment option. Objective The primary aim of this study is to evaluate the outcomes, complications, and comorbidities associated with EVT in patients with CVT. Methods A query of the 2015-2019 National (Nationwide) Inpatient Sample (NIS) was performed for patients admitted to hospitals with ICD-10 diagnosis codes for CVT. The usage of endovascular thrombectomy was identified using ICD-10 procedure codes. Demographic information, baseline comorbidities, complications, and discharge dispositions were compared between patients who underwent EVT and those who were managed medically. A multivariate logistic regression was performed to determine independent predictors of outcomes, while controlling for age, gender, cerebral edema/herniation, hemorrhage, mechanical ventilation, Elixhauser Comorbidity Index, and National Institute of Health Stroke Scale (NIHSS) severity. Odds ratios (OR) were calculated for each complication/outcome. Statistical significance was set at an alpha level of 0.05. All statistical analyses were performed using Statistical Product and Service Solutions (SPSS) Statistical Software Version 29. Results A total of 36,005 patients diagnosed with CVT were identified from 2015(Q4)-2019; of those, 325 (0.9%) underwent EVT. Patients who underwent EVT were older (49.28±19.08years vs 43.62±23.29 years, p < 0.001), more likely to be female (61.5% vs. 54.8%, p = 0.016), and had higher rates of comorbidities, such as diabetes mellitus (18.5% vs. 13.5%, p = 0.012), hypertension (47.7% vs. 31.3%, p < 0.001), and obesity (13.8% vs. 8.1%, p < 0.001). These patients also presented with more severe neurological symptoms, including higher NIHSS scores (13.15 vs. 6.17, p < 0.001), coma (30.8% vs. 11.2%, p < 0.001), and cerebral edema (43.1% vs. 15.5%, p < 0.001). Patients who instead received medical management had higher rates of sepsis (4.7% vs 1.5%, p = 0.008), and were more likely to undergo subsequent decompressive craniectomy (1.9% vs 0%, p = 0.011). Patients undergoing EVT had a higher incidence of in-hospital mortality (15.4% vs. 4.6%, OR 1.627, p = 0.007), were less likely to be discharged routinely (29.2% vs. 57%, OR 0.599, p < 0.001), and more likely to be transferred to a skilled nursing facility (44.6% vs. 20%, OR 3.22, p < 0.001). They also experienced higher rates of concomitant conditions, such as pulmonary embolism (7.7% vs. 3%, p < 0.001) and hemiplegia (33.8% vs. 10.5%, p < 0.001). Conclusions In this nationally-representative analysis, patients with CVT who underwent EVT were older, had higher income, were more likely to be female, and presented with more severe neurological conditions. Our results indicate that EVT in patients with CVT is associated with significant risks, including higher rates of inpatient mortality. Although our analysis attempts to adjust for confounding differences, it remains challenging to fully account for the increased baseline morbidity in patients undergoing EVT. As a result, the poorer outcomes observed in this cohort potentially reflect the severity of illness in these patients rather than the risks associated with EVT itself. Nonetheless, EVT remains an important treatment option for patients who fail medical management. Careful patient selection and tailored management strategies are essential to minimize risks and improve outcomes in this high-risk population. Further studies should focus on developing precise patient selection criteria to better identify which patients with CVT are most likely to benefit from EVT.